| SciPort RLP

2015 - 2017

Gene Regulation of the tumorsuppressor insulin-like growth factor-2 receptor (IGF2R) in human hepatocellular carcinoma (HCC) and its prognostic relevance

Dr. Anja,
PD Dr. Tim

2015 - 2017

Significance of DNA methylation and histone acetylation/methylation in the region of the gene locus 6q26-27 for the progression of hepatocellular carcinoma (HCC)

Dr. Anja,
PD Dr. Tim

2015 - 2019

CASTOR / MMY3004: Daratumumab-VD vs VD bei rezidiviertem Multiplen Myelom (577)

PD Dr. Markus

2015 - 2017

Analysis of single nucleotid polymorphisms (SNPs) in the insulin-like growth factor-2 receptor (IGF2R) promoter region of patients with hepatocellular carcinoma (HCC)

Dr. Anja,
PD Dr. Tim

2015 - 2016

Förderung der Versorgungsqualität von MDS-Patienten an der Universitätsmedizin Mainz

Univ.-Prof. Dr. Markus

2015 - 2017

Influence of transarterial chemoembolization (TACE) treatment of patients with HCC on the expression and regulation of insulin-like growth factor molecules and their receptors

Dr. Anja

2015 - 2018

Identifizierung diagnostischer Marker zur verbesserten Therapieentscheidung beim nodal-negativen Mammakarziniom

Univ.-Prof. Dr. Marcus,
Univ.-Prof. Dr. Wilfried,
Univ.-Prof. Dr. Ugur

2015 - 2017

Influence of transarterial chemoembolization (TACE) of patients with HCC on the regulation of insulin-like growth factor-2 receptor (IGF2R) and its prognostic relevance after liver transplantation

Dr. Anja,
PD Dr. Tim

2015 - 2019

Quizartinib oder Chemotherapie bei FLT3-positiven Patienten als zweite Therapie bei nicht wirksamer Ersttherapie oder bei Wiederauftreten der AML (#561)

Prof. Dr. Markus

2015 - 2020

VinoMetro - Phase II study of metronomic treatment with daily oral vinorelbine in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy

Univ.-Prof. Dr. Marcus

Klinikum

FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

Klinikum

FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz